All In Biotech

Drug Trial Radar · NCT07435038

Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS.

Last checked: Nov 19, 2026Latest source record: Sep 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

Jan 29, 2026

Primary completion

Dec 28, 2028

Study completion Oct 28, 2029

Sponsor

Sponsor type
Industry
First posted
Feb 27, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluate the safety and tolerability of BPI-572270 in adult patients with specific RAS mutant advanced solid tumors.

Conditions

  • Non-small Cell Lung Cancer (NSCLC)
  • Colorectal Cancer (CRC)
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • Advanced Solid Tumors

Interventions

  • BPI-572270Drug

    Oral Tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. DLTTime frame: up to 2 tears
  2. RP2DTime frame: up to 2 tears
  3. ORRTime frame: up to 3 tears

Locations

7 sites in 2 countries. Site status is shown where the registry gives one.

  • Blacktown Hospital

    Blacktown, New South Wales, Australia · Not yet recruiting

  • Scientia Clinical Research

    Randwick, New South Wales, Australia · Not yet recruiting

  • GenesisCare St Leonards, 7 Westbourne St, St Leonards

    Sydney, New South Wales, Australia · Not yet recruiting

  • Southern Oncology Clinical Research Unit (SOCRU)

    Bedford Park, South Australia, Australia · Not yet recruiting

  • Warringal Private Hospital

    Heidelberg, Victoria, Australia · Not yet recruiting

  • Linear Clinical Research Ltd

    Nedlands, Western Australia, Australia · Not yet recruiting

  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.